Abstract
Two new geldanamycin (GDM) analogues, (4S)-4,5-dihydro-4-hydroxygeldanamycin (1) and (4R)-4,5-dihydro-4-hydroxygeldanamycin (2), were identified from Streptomyces hygroscopicus 17997. Compounds 1 and 2 were not normal intermediates of GDM biosynthesis but shunt products of C-4,5 oxidation catalyzed by GdmP, a cytochrome P450 oxidase acting as a desaturase in GDM biosynthesis. Preliminary assays implied that, compared with GDM, 1 and 2 exhibited decreased cytotoxicity.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Benzoquinones* / chemistry
-
Benzoquinones* / metabolism
-
Benzoquinones* / pharmacology
-
Lactams, Macrocyclic* / chemistry
-
Lactams, Macrocyclic* / metabolism
-
Lactams, Macrocyclic* / pharmacology
-
Molecular Structure
-
NADPH-Ferrihemoprotein Reductase / metabolism*
-
Nuclear Magnetic Resonance, Biomolecular
-
Oxidation-Reduction
-
Streptomyces / chemistry*
-
Streptomyces / genetics
-
Streptomyces / metabolism
Substances
-
(4S)-4,5-dihydro-4-hydroxygeldanamycin
-
Benzoquinones
-
Lactams, Macrocyclic
-
NADPH-Ferrihemoprotein Reductase
-
geldanamycin